title: Shortening infusion times for infliximab administration.
authors.forename: M H
authors.initials: MH
authors.lastname: Buch
authors.forename: D
authors.initials: D
authors.lastname: Bryer
authors.forename: S
authors.initials: S
authors.lastname: Lindsay
authors.forename: B
authors.initials: B
authors.lastname: Rees-Evans
authors.forename: A
authors.initials: A
authors.lastname: Fairclough
authors.forename: P
authors.initials: P
authors.lastname: Emery
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D007263:Infusions, Parenteral; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D008727:Methotrexate